abstract |
7- (6- (2-Hydroxypropan-2-yl) pyridin-3-yl) -1-((trans) -4-methoxycyclohexyl) -3,4-dihydropyrazino [2,3-b] Providing solid form A of pyrazin-2 (1H) -one. A solid form of a compound of the formula: pharmaceutically acceptable salts, isotopes, and metabolites thereof. Use of the compound or a pharmaceutical composition containing the compound for the treatment of a disease, disorder, or symptom. [Selection figure] None |